Evidence map›Paper›PMID 34272374›Full record

ArticleNature communications2021

SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance.

Rémy Robinot, Mathieu Hubert, Guilherme Dias de Melo, Françoise Lazarini, Timothée Bruel, Nikaïa Smith, Sylvain Levallois, Florence Larrous, Julien Fernandes, Stacy Gellenoncourt and 15 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 173 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
173citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

173 citing papers in PubMed, 1 synthesis or guideline pooled it, 18 citations in OpenAlex.

  1. Gut distress and interventionFrontiers in public health · 2023
    Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. SARS-CoV-2 drives upregulation of EpCAM in respiratory epithelial cells with hypercellular profile during severe COVID-19.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Intrinsic OASL expression governs heterogeneity in interferon induction during influenza A virus infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  17. Article
  18. Review
  19. Review
  20. Article

113 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 1 country.

Rémy Robinot *Virus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France.ORCID 0000-0002-3651-0171
Mathieu Hubert *Virus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France.ORCID 0000-0002-2190-0177
Guilherme Dias de MeloLyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris, France.ORCID 0000-0003-0747-7760
Françoise LazariniPerception and Memory Unit, Institut Pasteur, Paris, France.ORCID 0000-0001-5572-6982
Timothée BruelVirus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France.ORCID 0000-0002-3952-4261
Nikaïa SmithTranslational Immunology Lab, Department of Immunology, Institut Pasteur, Paris, France.ORCID 0000-0002-0202-612X
Sylvain LevalloisBiology of Infection Unit, Institut Pasteur, Paris, France.ORCID 0000-0002-5805-1092
Florence LarrousLyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris, France.ORCID 0000-0003-0881-4263
Julien FernandesUtechS Photonics BioImaging, C2RT, Institut Pasteur, Paris, France.ORCID 0000-0001-8768-625X
Stacy GellenoncourtVirus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France.
Stéphane RigaudImage Analysis Hub, C2RT, Institut Pasteur, Paris, France.ORCID 0000-0003-2161-0927
Olivier GorgetteUtechS Ultrastructural BioImaging UBI, C2RT, Institut Pasteur, Paris, France.ORCID 0000-0003-2883-6101
Catherine ThouvenotUtechS Ultrastructural BioImaging UBI, C2RT, Institut Pasteur, Paris, France.ORCID 0000-0001-8784-3286
Céline TrébeauInstitut de l'Audition, Institut Pasteur, INSERM, Paris, France.
Adeline MalletUtechS Ultrastructural BioImaging UBI, C2RT, Institut Pasteur, Paris, France.ORCID 0000-0003-1604-7308
Guillaume DuménilUtechS Ultrastructural BioImaging UBI, C2RT, Institut Pasteur, Paris, France.
Samy GobaaBiomaterials and Microfluidics Core Facility, Institut Pasteur, Paris, France.ORCID 0000-0002-0125-8674
Raphaël EtournayInstitut de l'Audition, Institut Pasteur, INSERM, Paris, France.ORCID 0000-0002-2441-9274
Pierre-Marie LledoPerception and Memory Unit, Institut Pasteur, Paris, France.
Marc LecuitBiology of Infection Unit, Institut Pasteur, Paris, France.ORCID 0000-0002-4491-1063
Hervé BourhyLyssavirus Epidemiology and Neuropathology Unit, Institut Pasteur, Paris, France.ORCID 0000-0002-2608-5589
Darragh DuffyTranslational Immunology Lab, Department of Immunology, Institut Pasteur, Paris, France.ORCID 0000-0002-8875-2308
Vincent MichelInstitut de l'Audition, Institut Pasteur, INSERM, Paris, France. vincent.michel@pasteur.fr.ORCID 0000-0002-7025-4343
Olivier SchwartzVirus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France. olivier.schwartz@pasteur.fr.ORCID 0000-0002-0729-1475
Lisa A ChakrabartiVirus & Immunity Unit, Department of Virology, Institut Pasteur, Paris, France. chakra@pasteur.fr.ORCID 0000-0002-1895-3630
Institut Pasteur · FRCentre National de la Recherche Scientifique · FRInserm · FRHôpital Necker-Enfants Malades · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Understanding how SARS-CoV-2 spreads within the respiratory tract is important to define the parameters controlling the severity of COVID-19. Here we examine the functional and structural consequences of SARS-CoV-2 infection in a reconstructed human bronchial epithelium model. SARS-CoV-2 replication causes a transient decrease in epithelial barrier function and disruption of tight junctions, though viral particle crossing remains limited. Rather, SARS-CoV-2 replication leads to a rapid loss of the ciliary layer, characterized at the ultrastructural level by axoneme loss and misorientation of remaining basal bodies. Downregulation of the master regulator of ciliogenesis Foxj1 occurs prior to extensive cilia loss, implicating this transcription factor in the dedifferentiation of ciliated cells. Motile cilia function is compromised by SARS-CoV-2 infection, as measured in a mucociliary clearance assay. Epithelial defense mechanisms, including basal cell mobilization and interferon-lambda induction, ramp up only after the initiation of cilia damage. Analysis of SARS-CoV-2 infection in Syrian hamsters further demonstrates the loss of motile cilia in vivo. This study identifies cilia damage as a pathogenic mechanism that could facilitate SARS-CoV-2 spread to the deeper lung parenchyma.

Indexed as

SARS-CoV-2AnimalsAxonemeBasal BodiesCiliaCOVID-19CricetinaeCytokinesEpithelial CellsForkhead Transcription FactorsHumansLungMaleMesocricetusMucociliary ClearanceRespiratory MucosaCytokinesForkhead Transcription FactorsFOXJ1 protein, human

Identifiers

PMID34272374
PMCPMC8285531
OpenAlexW3169645742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.